Xizang Haisco Pharmaceutical Group Co Ltd Strategic Asset Allocation Index
Xizang Haisco Pharmaceutical Group Co Ltd strategic asset allocation index. Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Strategic Asset Allocation Index of 24.7% as of September 2023. Strategic assets (PP&E of CN¥1.01 Billion plus long-term investments of CN¥-) total CN¥1.01 Billion, measured against net assets of CN¥4.08 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Xizang Haisco Pharmaceutical Group Co Lt to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Xizang Haisco Pharmaceutical Group Co Ltd (2008–2022)
Strategic asset allocation index of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2022. This chart shows how Xizang Haisco Pharmaceutical Group Co Ltd's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2022. As of September 2023, the index stands at 24.7%, representing strategic assets of CN¥1.01 Billion against net assets of CN¥4.08 Billion CNY.
Xizang Haisco Pharmaceutical Group Co Ltd Strategic Asset Allocation Index by Year (2008–2022)
Xizang Haisco Pharmaceutical Group Co Ltd strategic asset allocation index by year from 2008 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002653 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 34.3% | CN¥1.07 Billion | CN¥1.07 Billion | CN¥- | CN¥3.13 Billion | ▼ -4.7 pp |
| 2021 | 38.9% | CN¥1.14 Billion | CN¥1.14 Billion | CN¥- | CN¥2.92 Billion | ▼ -0.5 pp |
| 2020 | 39.4% | CN¥1.13 Billion | CN¥1.13 Billion | CN¥- | CN¥2.85 Billion | ▼ -4.3 pp |
| 2019 | 43.7% | CN¥1.04 Billion | CN¥1.04 Billion | CN¥- | CN¥2.38 Billion | ▼ -23.7 pp |
| 2018 | 67.4% | CN¥1.34 Billion | CN¥859.14 Million | CN¥484.85 Million | CN¥1.99 Billion | ▲ +18.2 pp |
| 2017 | 49.1% | CN¥968.33 Million | CN¥768.00 Million | CN¥200.33 Million | CN¥1.97 Billion | ▲ +10.7 pp |
| 2016 | 38.4% | CN¥862.91 Million | CN¥706.62 Million | CN¥156.28 Million | CN¥2.25 Billion | ▲ +2.9 pp |
| 2015 | 35.6% | CN¥766.69 Million | CN¥662.20 Million | CN¥104.49 Million | CN¥2.16 Billion | ▲ +9.2 pp |
| 2014 | 26.4% | CN¥555.55 Million | CN¥555.55 Million | CN¥- | CN¥2.11 Billion | ▲ +2.7 pp |
| 2013 | 23.7% | CN¥456.77 Million | CN¥456.77 Million | CN¥- | CN¥1.93 Billion | ▲ +3.8 pp |
| 2012 | 20.0% | CN¥340.74 Million | CN¥340.74 Million | CN¥- | CN¥1.71 Billion | ▼ -12.1 pp |
| 2011 | 32.0% | CN¥245.99 Million | CN¥245.99 Million | CN¥- | CN¥767.76 Million | ▼ -2.7 pp |
| 2010 | 34.7% | CN¥157.30 Million | CN¥157.30 Million | CN¥- | CN¥453.09 Million | ▼ -42.2 pp |
| 2009 | 76.9% | CN¥103.91 Million | CN¥103.91 Million | CN¥- | CN¥135.17 Million | ▲ +41.1 pp |
| 2008 | 35.8% | CN¥76.99 Million | CN¥76.99 Million | CN¥- | CN¥214.95 Million | — |